Title | Application Due Date | Award Amount | Description |
---|---|---|---|
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) | Varies | The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339829 |
|
Office of Elementary and Secondary Education (OESE): Innovation and Early Learning Programs: Education Innovation and Research (EIR) Program—Early-Phase Grants Assistance Listing Number (ALN) 84.411C | $4,000,000 | Note: Each funding opportunity description is a synopsis of information in the Federal Register application notice. For specific information about eligibility, please see the official application notice. The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available on GPO Access at: http://www.…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339827 |
|
Afghan Women Economic Empowerment Through Leveraging the Private Sector | $1,481,481 | The U.S. Department of State’s Bureau of South and Central Asian Affairs (SCA) announces a Request for Statements of Interest (RSOI) for organizations to submit a statement of interest (SOI) to carry out a $1.5 million program to advance the economic empowerment of Afghan women in Afghanistan and other South and Central Asian countries. The proposed program would launch a platform through which businesses, non-profits, and international government leaders in the U.S. and countries…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339832 |
|
Conservation Innovation Grants State Program | $150,000 | Federal Awarding Agency Name: U.S. Department of Agriculture – Natural Resources Conservation Service (NRCS), Commodity Credit Corporation (CCC) Notice of Funding Opportunity Title: Announcement for Program Funding for NRCS’ Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2022 – LOUISIANA Notice of Funding Opportunity Number: USDA-NRCS-LA-CIG-22-NOFO0001208 Assistance Listing: This program is listed in the Assistance Listings on SAM.gov under…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339834 |
|
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) | $200,000 | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Technology-enhanced training products for the health and safety training of: hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biological hazard response, infectious disease response, and medical…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339851 |
|
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) | Varies | The blood brain barrier (BBB) is a target of both the HIV virus and substances of abuse. It is a site of entry for HIV infected monocytes and macrophages that can traverse the BBB either paracellularly or transcellularly. HIV viral proteins can also attack astrocytes and tight junctions of BBB directly and compromise its integrity, resulting in the crossing of the virus, as well as abused substances, into the brain. Meanwhile, many substances of abuse cause BBB dysfunction. Because BBB…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339850 |
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) | Varies | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340173 |
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) | Varies | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340174 |
|
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) | Varies | The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary statistical analyses of existing dental, oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases. https://www.grants.gov/web/grants/view-opportunity.html?oppId=340195 |
Displaying 19 - 27 of 295